Literature DB >> 19439108

The role of macrophages in inflammatory bowel diseases.

Sigrid E M Heinsbroek1, Siamon Gordon.   

Abstract

The small and large intestine contain the largest number of macrophages in the body and these cells are strategically located directly underneath the epithelial layer, enabling them to sample the lumen. Such intestinal macrophages have a different phenotype from other tissue macrophages in that they ingest and may kill microbes but they do not mediate strong pro-inflammatory responses upon microbial recognition. These properties are essential for maintaining a healthy intestine. It is generally accepted that tolerance to the intestinal flora is lost in inflammatory bowel diseases, and genes involved in microbial recognition, killing and macrophage activation have already been associated with these diseases. In this review, we shed light on the intestinal macrophage and how it influences intestinal immunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19439108     DOI: 10.1017/S1462399409001069

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  35 in total

1.  Persistent accumulation of gut macrophages with impaired phagocytic function correlates with SIV disease progression in macaques.

Authors:  Zachary D Swan; Anthea L Bouwer; Elizabeth R Wonderlich; Simon M Barratt-Boyes
Journal:  Eur J Immunol       Date:  2017-07-24       Impact factor: 5.532

Review 2.  Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.

Authors:  Darren Michael Moss; Marco Siccardi
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

3.  Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis.

Authors:  Cheng-Ying Chiu; Beate Gomolka; Cordula Dierkes; Nora R Huang; Maik Schroeder; Martin Purschke; Dieter Manstein; Bindi Dangi; Karsten H Weylandt
Journal:  Inflamm Res       Date:  2012-05-23       Impact factor: 4.575

4.  Depletion and reconstitution of macrophages in mice.

Authors:  Shelley B Weisser; Nico van Rooijen; Laura M Sly
Journal:  J Vis Exp       Date:  2012-08-01       Impact factor: 1.355

5.  Dual TNF-α/IL-12p40 Interference as a Strategy to Protect Against Colitis Based on miR-16 Precursors With Macrophage Targeting Vectors.

Authors:  Zhen Huang; Junting Ma; Mengjie Chen; Haoyang Jiang; Yong Fu; Jingjing Gan; Lei Dong; Junfeng Zhang; Jiangning Chen
Journal:  Mol Ther       Date:  2015-06-15       Impact factor: 11.454

6.  Induction and activation of adaptive immune populations during acute and chronic phases of a murine model of experimental colitis.

Authors:  Lindsay J Hall; Emilie Faivre; Aoife Quinlan; Fergus Shanahan; Kenneth Nally; Silvia Melgar
Journal:  Dig Dis Sci       Date:  2010-05-14       Impact factor: 3.199

7.  L13a-dependent translational control in macrophages limits the pathogenesis of colitis.

Authors:  Darshana Poddar; Ravinder Kaur; William M Baldwin; Barsanjit Mazumder
Journal:  Cell Mol Immunol       Date:  2015-07-13       Impact factor: 11.530

Review 8.  Nanomedicines for dysfunctional macrophage-associated diseases.

Authors:  Hongliang He; Shobha Ghosh; Hu Yang
Journal:  J Control Release       Date:  2017-01-03       Impact factor: 9.776

Review 9.  Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease.

Authors:  Marnix A Lameijer; Jun Tang; Matthias Nahrendorf; Robert H J Beelen; Willem J M Mulder
Journal:  Expert Rev Mol Diagn       Date:  2013-07       Impact factor: 5.225

10.  VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease.

Authors:  Silvia D'Alessio; Carmen Correale; Carlotta Tacconi; Alessandro Gandelli; Giovanni Pietrogrande; Stefania Vetrano; Marco Genua; Vincenzo Arena; Antonino Spinelli; Laurent Peyrin-Biroulet; Claudio Fiocchi; Silvio Danese
Journal:  J Clin Invest       Date:  2014-08-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.